Curis, Inc. (CRIS)
0.4071
-0.10
(-19.86%)
USD |
NASDAQ |
Oct 16, 16:00
0.4174
+0.01
(+2.53%)
After-Hours: 20:00
Curis EPS Diluted (Quarterly) : -4.017 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.017 |
| March 31, 2026 | -24.99 |
| December 31, 2025 | 24.58 |
| September 30, 2025 | -9.858 |
| June 30, 2025 | -13.61 |
| March 31, 2025 | -1.250 |
| December 31, 2024 | -25.08 |
| September 30, 2024 | -1.699 |
| June 30, 2024 | -2.029 |
| March 31, 2024 | -2.053 |
| December 31, 2023 | -2.029 |
| September 30, 2023 | -2.129 |
| June 30, 2023 | -2.474 |
| March 31, 2023 | -2.393 |
| December 31, 2022 | -2.350 |
| September 30, 2022 | -2.835 |
| June 30, 2022 | -3.478 |
| March 31, 2022 | -3.516 |
| December 31, 2021 | -2.973 |
| September 30, 2021 | -2.413 |
| June 30, 2021 | -2.368 |
| March 31, 2021 | -2.170 |
| December 31, 2020 | -2.265 |
| September 30, 2020 | -2.190 |
| June 30, 2020 | -3.395 |
| Date | Value |
|---|---|
| March 31, 2020 | -5.636 |
| December 31, 2019 | -5.184 |
| September 30, 2019 | -3.877 |
| June 30, 2019 | -4.351 |
| March 31, 2019 | -5.963 |
| December 31, 2018 | -3.587 |
| September 30, 2018 | -4.356 |
| June 30, 2018 | -5.20 |
| March 31, 2018 | -7.00 |
| December 31, 2017 | -489.48 |
| September 30, 2017 | -11.00 |
| June 30, 2017 | -10.00 |
| March 31, 2017 | -11.00 |
| December 31, 2016 | -8.00 |
| September 30, 2016 | -21.00 |
| June 30, 2016 | -9.00 |
| March 31, 2016 | -7.00 |
| December 31, 2015 | -10.00 |
| September 30, 2015 | -4.00 |
| June 30, 2015 | -6.00 |
| March 31, 2015 | -30.00 |
| December 31, 2014 | -7.00 |
| September 30, 2014 | -6.00 |
| June 30, 2014 | -2.00 |
| March 31, 2014 | -6.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.581M |
| Total Expenses (Quarterly) | 8.581M |
| Enterprise Value | -3.780M |
| Earnings Yield | -3.51K% |
| Normalized Earnings Yield | -7285.88 |